ABSTRACT
T
here is accumulating scientific evidence that vitamin D supplements can be protective against some chronic diseases. [1] [2] [3] [4] [5] [6] The National Institutes of Health supports a large ongoing study to test for such effects. 2 Investigators have begun to test for brain imaging findings that correlate with serum vitamin D levels. [6] [7] [8] The January 2010 issue of Neurology contained 3 studies that evaluated hundreds of elderly subjects to test for a relationship between vitamin D status and dementia or cognitive impairment. 4, 8, 9 The Annweiler and Buell studies evaluated women only and both women and men, respectively; both showed a significant relationship between low vitamin D and dementia or cognitive impairment. The Slinin report only evaluated men and showed a trend for a relationship between vitamin D and cognitive impairment. A later study by Annweiler et al, 10 with male and female subjects, showed lower serum 25-hydroxyvitamin D (Vit D) in patients with mild cognitive impairment compared with cognitively healthy individuals. A prospective study with 6-year follow-up involving more than 800 elderly patients showed significant increased risk of cognitive decline in those with low Vit D compared with sufficient levels.
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Studies have begun to examine the relationship between Vit D and brain MR findings in mice and in humans with significant disease. In 2010, Fernandes de Abreu et al 7 The purpose of this study was to determine if Vit D levels are associated with white matter abnormalities in an outpatient population by MR imaging.
MATERIALS AND METHODS
With the use of our hospital information system, we identified patients 30 -69 years of age who had been tested for Vit D and also had a routine MR brain study within a 90-day period for our pilot study. From each decade of age we then selected the 7 patients with the highest and the 7 with the lowest Vit D levels for review. Vit D level, age, race (black or white), history of hypertension, diabetes, and use of dietary vitamin D supplementation were evaluated. All MR images were de-identified in compliance with Health Insurance Portability and Accountability Act regulations. Our institutional review board approved the study.
Image Acquisition and Analysis
MR imaging studies were all performed on 1.5T Siemens Espree and Avanto or GE LX2 and Excite magnets by use of standard institutional protocols and included T1 sagittal/axial, T2 axial, FLAIR axial, and diffusion-weighted sequences. They were evaluated separately by 2 subspecialty-certified neuroradiologists, with more than 20 years (J.R.M.) and 16 years (W.J.A.) of experience interpreting brain imaging, for presence of infarction, atrophy (graded 1-4), and perivascular spaces. White matter T2 hyperintensities were evaluated for type: punctate, defined as 5 mm or less, versus confluent, greater than 5 mm in diameter; confluent lesions were further quantified by number and greatest diameter (mm). White matter T2 hyperintensities were also evaluated for location; juxtacortical within 3 mm of cortex, periventricular within 3 mm of ventricle, or central (neither juxtacortical nor periventricular). When there was less than 7 mm between cortex and the ventricle, the distance was divided into thirds for localization.
Atrophy was further quantified by use of the bicaudate ratio, (minimum intercaudate distance divided by brain width along the same line), which reflects subcortical atrophy (Fig 1) . 13 MR imaging scans from the 25 participants more than 50 years of age were assessed for total WMH volume by use of MRIcro software (http://www.mccauslandcenter.sc.edu/mricro/mricro/ mricro.html). Rater W.J.A., an experienced neuroradiologist, performed manual volumetric measurement by use of axial 5-mm FLAIR images.
Statistical Analysis
We used Pearson and Spearman correlations to test for a significant relationship between MR findings and serum vitamin D levels. For analysis, we divided the patients into 3 groups: 1) the entire cohort; 2) those aged 50 and above; and 3) only those not taking supplements. The neuroradiologists' findings were evaluated for strength of agreement; their MR findings were evaluated separately and together. The punctate and confluent white matter changes were evaluated separately and in various combinations, for example, periventricular plus central plus juxtacortical punctate foci.
RESULTS
Patient profiles are shown in Table 1 . Nine subjects were excluded because of incomplete MR imaging or confounding pathology (eg, brain tumor). Note the much higher incidence of black subjects in the low Vit D group and the marked increase in subjects taking dietary vitamin D supplementation in the higher Vit D group, 15 compared with 2 in the low Vit D group. There is also a larger ratio of women to men in the higher Vit D group, 22:4 compared with the low Vit D group, 14:7. Four of the 22 patients younger than 50 years of age had WMH compared with 20 of the 25 patients ages 50 and above. The incidence of hypertension (including uncontrolled, blood pressure Ͼ140/90) and diabetes (including uncontrolled, fasting glucose Ͼ109) was similar in both groups.
Statistical Analysis
Initial review by the combined readers of the entire cohort by use of Spearman correlation showed a significant nega- Patients with migraine showed strong relationships with punctate WMH (periventricular P ϭ .013, central P ϭ .004). A significant relationship was also seen with size and number of confluent WMH in the periventricular region (P ϭ .028 and .04, respectively) ( Table 2 ).
Significant relationships were identified between all location punctate WMH and hypertension (juxtacortical, P ϭ .023; central, P ϭ .001; periventricular, P ϭ .018). The number of juxtacortical confluent WMH was significantly related (P ϭ .049); periventricular confluent WMH were related by number and size (P ϭ .008 and P ϭ .001, respectively) ( Table 3 ). The relationship between WMH and Vit D is attenuated when controlling for hypertension.
There was fair to moderate agreement between the 2 neuroradiologist evaluators. Interobserver values ranged from 0.206 -0.532 except for central confluent lesion number when value was 0.125. The P value for all WMH by type and location was Ͻ.001 except for central and juxtacortical maximum size confluent lesions when P ϭ .031 and P ϭ .003, respectively (Table 4) .
DISCUSSION
We found a significant relationship between WMH and low Vit D in healthy outpatients ages 50 years and above. The relationship is stronger and more extensive when the patients taking supplemental vitamin D are excluded. We were further able to characterize the significant WMH as confluent in the juxtacortical white matter and punctate in the combined periventricular/central white matter.
The presence of WMH is concerning because of the known strong association with reduced cognition. [14] [15] [16] [17] [18] [19] The Austrian Stroke Prevention Study showed that baseline grading of WMH was a better predictor for progression of cognitive difficulties than age or the presence of hypertension. 20 However, the presence of hypertension and diabetes are also associated with cognitive decline. 21, 22 The exact mechanism by which low vitamin D might be related to reduced cognition or the development of WMH is not known. It has been proposed that the cognitive dysfunction seen with low Vit D is more specifically caused by impaired mental shifting and information updating involving the dorsolateral circuit of the frontosubcortical neuronal circuit. 23 Possible explanations may involve modulation of neurotrophins, calcium binding growth factors, and inflammatory cytokines. 1 It has been suggested that Vit D has an important role in the differentiation and axonal adhesion of oligodendrogliocytes in the developing brain, with low Vit D increasing oligodendroglial apoptosis. This would prime an appropriate individual for the subsequent development of multiple sclerosis. 24 Our findings concur with the 2 prior studies that investigated the relationship of Vit D and MR findings. The Buell study 8 found a significant relationship between Vit D and WMH volume in older debilitated patients with average age of 73 years. Our patients are healthier and younger, with an average age of 59 years. This increases the range of patients in whom low Vit D should be considered in the differential of WMH. The Weinstock-Guttman study 6 evaluated patients with MS for a relationship with Vit D and WMH. They did not find a significant relationship, but their patients were younger, with an average age of 46 years. We also did not find a relationship in younger patients. Furthermore, having a higher baseline volume of WMH in patients with multiple sclerosis, a larger number of subjects would be necessary to establish a significant relationship with a small number of additional causes for WMH.
A more recent 5-year longitudinal study of relapsing MS evaluated changes in MRI and clinical status relative to vitamin D levels. The study included 469 patients with 2362 3T MR examinations; the average age was 42 years. They correlated baseline and subsequent vitamin D levels with the development of WMH, gadolinium enhancement, clinical disability, and relapses. There were significant reductions in new WMH, gadolinium-enhancing lesions, and disability correlating with each 10 ng/mL increase in vitamin D level. The clinical relapse rate was lower but not statistically significant. 12 Our analysis is most limited by measurement of the vitamin D level, which represents a single point in a dynamic process. When one considers the clinical factors that influence the blood level of vitamin D and the clinical profile of WMH, it is apparent why statistical analysis needs to adjust for dietary vitamin D supplementation. Measured vitamin D changes with the season and with individual exposure to sunlight and it is stored in the body for up to 2 months. Vitamin D production decreases in darker skinned individuals and with age. 3, 25 The vitamin D level of an older patient taking a supplement does not reflect levels before taking supplements when WMH appeared. White matter T2 hyperintensities accumulate over a lifetime as they are only rarely reversible and then associated with acute illness such as Posterior Reversible Encephalopathy Syndrone or hepatic encephalopathy. Our patients probably had WMH years before they were examined with the use of MR and before they supplemented their diet with vitamin D. We did not control the patient selection process regarding the reason for medical and imaging evaluation, which could lead to unforeseen bias. Potentially problematic in our patient population is the presence of hypertension and diabetes mellitus, which are closely related confounders known to increase WMH. [26] [27] [28] [29] There is a similar incidence of controlled and uncontrolled hypertension (8 of 11, 73%; 10 of 14, 71%) and diabetes (4 of 11, 36%; 3 of 14, 21%) in the low and high Vit D groups. This is a cross-sectional pilot study with a limited number of subjects and can only establish association but not causation. Future studies should consider including a larger cohort with more rigorous patient selection, especially patients who do not supplement their diet with vitamin D.
White matter T2 hyperintensities are a pathologic end point. Other MR techniques such as magnetization transfer, mean diffusivity, fractional anisotropy, perfusion, and MR spectroscopy have shown abnormalities in normal-appearing white matter in patients with MS. 30 Diffusion abnormalities are also seen in Alzheimer disease. 31 Maillard et al, 19 in a study of elderly subjects with cognitive health, cognitive impairment, and Alzheimer disease, showed an increased risk for white matter conversion to WMH in patients with lower fractional anisotropy and higher FLAIR signal in normal-appearing white matter. Optimized future studies should be longitudinal and use these MR techniques.
CONCLUSIONS
This study shows a previously unreported significant relationship between low Vit D levels and white matter injury evidenced by increased juxtacortical confluent WMH in healthy outpatients between the ages of 50 -69 years. There was no relationship in our patients ages 31-49 years. We showed a more powerful relationship in patients who did not take vitamin D supplements because normal Vit D in such patients could disguise a history of chronic low Vit D before the onset of supplementation. This pilot study has significant limitations including a small number of subjects and patient selection factors. Longitudinal studies with a greater number and control of subjects and additional MR metrics are indicated to establish a more definitive relationship.
